Article révisé par les pairs
| Résumé : | Some recent advances in the search for tumor‐specific immunity in man are reviewed. The development of new techniques for the in vitro detection of tumor‐induced immune reactions has led to the discovery of both cell‐mediated and humoral immunity induced by a variety of human tumors. Malignant melanomas, Burkitt's lymphomas, neuroblastomas, and choriocarcinomas rank high on the list of antigenic tumors and are associated with a better than average prognosis. Immunotherapy based on the antigenic differences between normal and tumor cells is briefly discussed. Copyright © 1970 American Cancer Society |
